BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 33824314)

  • 1. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology.
    Cheng K; Zhao R; Li Y; Qi Y; Wang Y; Zhang Y; Qin H; Qin Y; Chen L; Li C; Liang J; Li Y; Xu J; Han X; Anderson GJ; Shi J; Ren L; Zhao X; Nie G
    Nat Commun; 2021 Apr; 12(1):2041. PubMed ID: 33824314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
    Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
    Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor.
    Wang S; Huang W; Li K; Yao Y; Yang X; Bai H; Sun W; Liu C; Ma Y
    Int J Nanomedicine; 2017; 12():6813-6825. PubMed ID: 28979120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Surface Display of mRNA Antigens by Bacteria-Derived Outer Membrane Vesicles for a Personalized Tumor Vaccine.
    Li Y; Ma X; Yue Y; Zhang K; Cheng K; Feng Q; Ma N; Liang J; Zhang T; Zhang L; Chen Z; Wang X; Ren L; Zhao X; Nie G
    Adv Mater; 2022 May; 34(20):e2109984. PubMed ID: 35315546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
    Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.
    Salverda ML; Meinderts SM; Hamstra HJ; Wagemakers A; Hovius JW; van der Ark A; Stork M; van der Ley P
    Vaccine; 2016 Feb; 34(8):1025-33. PubMed ID: 26801064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A "Plug-and-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-binding Domain.
    Feng R; Li GC; Jing HM; Liu C; Xue RY; Zou QM; Li HB
    J Vis Exp; 2022 Jul; (185):. PubMed ID: 35938846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens.
    Weyant KB; Oloyede A; Pal S; Liao J; Jesus MR; Jaroentomeechai T; Moeller TD; Hoang-Phou S; Gilmore SF; Singh R; Pan DC; Putnam D; Locher C; de la Maza LM; Coleman MA; DeLisa MP
    Nat Commun; 2023 Jan; 14(1):464. PubMed ID: 36709333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Display of Recombinant Proteins on Bacterial Outer Membrane Vesicles by Using Protein Ligation.
    van den Berg van Saparoea HB; Houben D; de Jonge MI; Jong WSP; Luirink J
    Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29439988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteome-minimized outer membrane vesicles from
    Zanella I; König E; Tomasi M; Gagliardi A; Frattini L; Fantappiè L; Irene C; Zerbini F; Caproni E; Isaac SJ; Grigolato M; Corbellari R; Valensin S; Ferlenghi I; Giusti F; Bini L; Ashhab Y; Grandi A; Grandi G
    J Extracell Vesicles; 2021 Feb; 10(4):e12066. PubMed ID: 33643549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
    Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers based on bacterial membrane materials for cancer vaccine delivery.
    Zhao X; Zhao R; Nie G
    Nat Protoc; 2022 Oct; 17(10):2240-2274. PubMed ID: 35879454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing immune responses of ESC-based TAA cancer vaccines with a novel OMV delivery system.
    Jin M; Huo D; Sun J; Hu J; Liu S; Zhan M; Zhang BZ; Huang JD
    J Nanobiotechnology; 2024 Jan; 22(1):15. PubMed ID: 38166929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA Delivery Platform Based on Bacterial Outer Membrane Vesicles for Tumor Vaccine.
    Gao X; Li Y; Nie G; Zhao X
    Bio Protoc; 2023 Jul; 13(13):e4774. PubMed ID: 37456344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging of bacterial outer membrane vesicles based on bacterial surface display.
    Szöllősi D; Hajdrik P; Tordai H; Horváth I; Veres DS; Gillich B; Shailaja KD; Smeller L; Bergmann R; Bachmann M; Mihály J; Gaál A; Jezsó B; Barátki B; Kövesdi D; Bősze S; Szabó I; Felföldi T; Oszwald E; Padmanabhan P; Gulyás BZ; Hamdani N; Máthé D; Varga Z; Szigeti K
    Sci Rep; 2023 Oct; 13(1):18752. PubMed ID: 37907509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine-linked HPV-associated E7 displaying bacteria-derived outer membrane vesicles as a potent antigen-specific cancer vaccine.
    Wang S; Chen CC; Hu MH; Cheng M; Tu HF; Tsai YC; Yang JM; Wu TC; Huang CH; Hung CF
    J Transl Med; 2024 Apr; 22(1):378. PubMed ID: 38649894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach.
    Daleke-Schermerhorn MH; Felix T; Soprova Z; Ten Hagen-Jongman CM; Vikström D; Majlessi L; Beskers J; Follmann F; de Punder K; van der Wel NN; Baumgarten T; Pham TV; Piersma SR; Jiménez CR; van Ulsen P; de Gier JW; Leclerc C; Jong WS; Luirink J
    Appl Environ Microbiol; 2014 Sep; 80(18):5854-65. PubMed ID: 25038093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
    Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
    Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.
    Lei EK; Azmat A; Henry KA; Hussack G
    Appl Microbiol Biotechnol; 2024 Feb; 108(1):232. PubMed ID: 38396192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.